HC Wainwright & Co. Reiterates Buy on Sernova Biotherapeutics, Maintains C$1 Price Target

Benzinga · 3d ago
HC Wainwright & Co. analyst Joseph Pantginis reiterates Sernova Biotherapeutics (TSX:SVA) with a Buy and maintains C$1 price target.